MONTECUCCO, ALESSANDRA
 Distribuzione geografica
Continente #
AS - Asia 2.147
NA - Nord America 1.566
EU - Europa 1.007
SA - Sud America 369
AF - Africa 37
Continente sconosciuto - Info sul continente non disponibili 21
OC - Oceania 5
Totale 5.152
Nazione #
US - Stati Uniti d'America 1.511
SG - Singapore 1.028
RU - Federazione Russa 658
CN - Cina 415
BR - Brasile 287
HK - Hong Kong 221
VN - Vietnam 198
FR - Francia 128
KR - Corea 84
IT - Italia 79
JP - Giappone 50
IN - India 33
BD - Bangladesh 32
DE - Germania 29
NL - Olanda 29
GB - Regno Unito 27
CA - Canada 25
AR - Argentina 23
CO - Colombia 21
FI - Finlandia 14
EC - Ecuador 13
ID - Indonesia 13
MX - Messico 13
IQ - Iraq 12
IL - Israele 10
ZA - Sudafrica 9
CL - Cile 8
MA - Marocco 8
PL - Polonia 7
SA - Arabia Saudita 7
TR - Turchia 7
VE - Venezuela 7
PE - Perù 6
EG - Egitto 5
MY - Malesia 5
PK - Pakistan 5
UA - Ucraina 5
AZ - Azerbaigian 4
JO - Giordania 4
KE - Kenya 4
PH - Filippine 4
SE - Svezia 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
AU - Australia 3
BE - Belgio 3
ET - Etiopia 3
LT - Lituania 3
TT - Trinidad e Tobago 3
BH - Bahrain 2
BO - Bolivia 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
ES - Italia 2
GR - Grecia 2
GT - Guatemala 2
JM - Giamaica 2
KZ - Kazakistan 2
LU - Lussemburgo 2
NZ - Nuova Zelanda 2
RO - Romania 2
SN - Senegal 2
SV - El Salvador 2
TH - Thailandia 2
AO - Angola 1
AT - Austria 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CG - Congo 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EE - Estonia 1
HN - Honduras 1
HU - Ungheria 1
IE - Irlanda 1
KH - Cambogia 1
LB - Libano 1
LC - Santa Lucia 1
LV - Lettonia 1
NG - Nigeria 1
NI - Nicaragua 1
OM - Oman 1
PA - Panama 1
PY - Paraguay 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
UY - Uruguay 1
ZM - Zambia 1
Totale 5.131
Città #
Singapore 615
Santa Clara 568
Hong Kong 218
San Jose 212
Hefei 197
Ashburn 114
Lauterbourg 111
Seoul 82
Ho Chi Minh City 73
Beijing 64
Dallas 44
Hanoi 44
Los Angeles 41
Tokyo 39
Buffalo 21
Pavia 15
São Paulo 15
Frankfurt am Main 14
New York 14
Orem 13
Helsinki 12
Chicago 11
Da Nang 11
Minamishinagawa 11
Atlanta 10
Brasília 9
Bogotá 8
Düsseldorf 8
Milan 8
Houston 7
Philadelphia 7
Quito 7
Washington 7
Bengaluru 6
Brooklyn 6
Chennai 6
Haiphong 6
Naples 6
Phoenix 6
Rio de Janeiro 6
Toronto 6
Amsterdam 5
Baghdad 5
Cleveland 5
Guayaquil 5
Las Vegas 5
Lima 5
Montreal 5
Ninh Bình 5
Rome 5
Warsaw 5
Amman 4
Baku 4
Guangzhou 4
Jacksonville 4
London 4
Medellín 4
Miami 4
Poplar 4
Santo André 4
Shanghai 4
The Bronx 4
Thái Nguyên 4
Addis Ababa 3
Albany 3
Beckley 3
Belo Horizonte 3
Biên Hòa 3
Bologna 3
Buon Ma Thuot 3
Cairo 3
Caracas 3
Charlotte 3
Council Bluffs 3
Dhaka 3
Duque de Caxias 3
Fayetteville 3
Hải Dương 3
Juiz de Fora 3
Kuala Lumpur 3
Lahore 3
Memphis 3
Milwaukee 3
Nairobi 3
New Delhi 3
Nha Trang 3
Phủ Lý 3
Porcari 3
Queens 3
Ribeirão Preto 3
Salvador 3
Santiago 3
Scarborough 3
Stockholm 3
São Bernardo do Campo 3
São José do Rio Preto 3
The Dalles 3
Thái Bình 3
Turin 3
Virginia Beach 3
Totale 2.887
Nome #
The replication factory targeting sequence/PCNA- binding site is required in G1 to control the phosphorylation status of DNA ligase I 691
DNA ligase I deficiency activates the ATM/dependent DNA damage checkpoint and affects cell adhesion. 76
Rat liver DNA ligases: catalytic properties of a novel form of DNA ligase 76
Cell cycle-dependent dynamic association of cyclin/Cdk complexes with human DNA replication proteins. 72
Heat shock affects mitotic segregation of human chromosomes bound to stress-induced satellite III RNAs 72
Chronic Replication Problems Impact Cell Morphology and Adhesion of DNA Ligase I Defective Cells 66
Identification of protein and sequence elemento involved in the acivity of the lamin B2 origin 65
Alteration of DNA structure: the common result of the interaction between DNA and physical and chemical agents 64
CorrelaGenes: a new tool for the interpretation of the human transcriptome. 63
Cellular response to etoposide treatment. 59
CorrelaGenes: a new tool for the interpretation of the human trascriptome. 58
A novel target in DNA metabolism for cytotoxic drugs 57
Inside complex disorder pathways through gene expression analysis 57
Biologia Molecolare e Cellulare della Replicazione del DNA. 53
"CELL CULTURING INTO HIGH ASPECT-RATIO ONE-DIMENSIONAL SILICON PHOTONIC CRYSTALS: TOWARD CELL-BASED BIOSENSORS", 51
Overexpression of a phosphomimetic mutant of DNA ligase I leads to replication-dependent DNA damage and impacts cell morphology without blocking cell cycle progression 50
TSPYL2 is a novel regulator of SIRT1 and p300 activity in response to DNA damage 50
CorrelaGenes: a new tool for the interpretation of the human transcriptome 50
DNA damage hampers cell morphology and motility 50
The Krebs Cycle Connection: Reciprocal Influence Between Alternative Splicing Programs and Cell Metabolism 49
Claspin inhibition leads to fragile site expression. 49
DNA Ligases 48
DNA ligase I-deficiency leads to replication-dependent DNA damages and impacts on cell morphology without blocking cell cycle progression. 47
MOLECULAR MECHANISMS OF ETOPOSIDE 47
A missense MT-ND5 mutation in differentiated Parkinson Disease cytoplasmic hybrid induces ROS-dependent DNA Damage Response amplified by DROSHA 46
Pre-mRNA processing factors meet the DNA damage response 44
The cell response to replicationdefects affects alternative splicing programs and cell morphology 44
Chronic replication stress impacts on cell morphology and adhesion 44
A new cell-selective three-dimensional microincubator based on silicon photonic crystals. 43
Splicing Factor SF2/ASF at the crossroad between cell proliferation, differentiation and the DNA damage response. 43
The role of prelamin A post-translational maturation in stress response and 53BP1 recruitment 42
Editorial: DNA and RNA metabolism meet at chromatin to control genome stability 42
DNA ligase I and Nbs1 proteins associate in a complex and colocalize at replication factories. 41
Replication Factories and Foci 41
Signs of genomic DNA damage in mitochondrial complex I-mutated cytoplasmic hybrids cell lines from Parkinson's patients 40
Cytoplasmatic hybrids (PD cybrids) as a model system to investigate genome stability in Parkinson's disease 40
The cell response to replication defects affects alternative splicing programs and cell morphology 39
Phosphorylation of SRSF1 is modulated by replicational stress. 39
The dispersal of replication proteins after Etoposide treatment requires the cooperation of Nbs1 with the ataxia telangiectasia Rad3-related/Chk1 pathway. 39
Dynamics of replication compartments in response to DNA damaging agents. 38
L-ATP is recognized by some cellular and viral enzymes: does chance drive enzymic enantioselectivity? 38
DNA replication is intrinsically hindered in terminally differentiated myotubes. 38
Comparti replicativi nel ciclo cellulare e in risposta al danno 38
A three-dimensional platform based on high aspect-ratio silicon photonic crystal for optofluidic and biosensing applications 38
A new mutation in mitochondrial DNA of Parkinson's patient is associated with signs of genomic DNA damage 38
The alternative splicing side of cancer 38
Late induction of human DNA ligase I after UV-C irradiation 37
Replication Factories and Foci 37
Lack of discrimination between DNA ligases I and III by two classes of inhibitors, anthracyclines and distamycins 36
Phosphorylation of SR proteins is modulated during the cell response to DNA damage 36
Pharmacological and Molecular Evidence for Dopamine D1 Receptor Expression by Striatal Astrocytes in Culture 36
Dynamics of replication compartments in response to DNA damaging agents 35
Identification of protein and sequence elemento involved in the acivity of the lamin B2 origin. 35
Etoposide induces the dispersal of DNA ligase I from replication factories. 35
Replication Factories and Foci 35
DNA ligase I is recruited to sites of DNA replication by an interaction with proliferating cell nuclear antigen: identification of a common targeting mechanism for the assembly of replication factories 34
Is DNA sequence sufficient to specify DNA replication origins in metazoan cells? 33
Temperature influences both cytotoxicity and DNA nicking efficiency of the antitumor distamycin analogue FCE24517 33
Meccanismo d'azione di estrogeni nel Sistema Nervoso Centrale di mammifero 33
Regulation of splicing factor SF2/ASF in response to proliferation, differentiation and DNA damage 33
A pRB-independent mechanism preserves the postmitotic state in terminally differentiated skeletal muscle cells. 32
Dynamics of replication compartments in response to DNA damaging agents. 32
Investigation of cell culturing on high-aspect-ratio three-dimensional silicon microstructures. 31
DNA ligase I deficiency activates the ATM-dependent DNA damage checkpoint and affects cell adhesion. 31
DNA replication: a complex matter 31
Modulation of DNA replication/repair protein complexes during the cell cycle and in response to DNA damage 31
DNA ligase I-deficient cell lines as a model for studying the cellular response to endogenous DNA damages. 31
Isolation of a type I topoisomerase from carrot cells 30
AMP-dependent DNA relaxation catalyzed by DNA ligase occurs by a nicking-closing mechanism 30
Genetic and Epigenetic Control of Genome Stability 30
Replicazione del DNA 30
Oncogenetics and proteomics of DNA replication 30
An insight into the abundant proteome of 46BR.1G1 fibroblasts deficient of DNA ligase I. 30
Recruitment of replicative factors to DNA replication factories: the human DNA ligase I model 30
Genetic mapping and expression analysis of the murine DNA ligase I gene 29
Multiple roles of DNA ligase at the replication fork 29
DNA ligase I deficiency activates the ATM-dependent DNA damage checkpoint 28
"TOWARDS A NEW LABEL-FREE CYTOMETRIC ANALYSIS BASED ON SILICON PHOTONIC CRYSTALS", 28
DNA ligase I is dephosphorylated during the execution step of etoposide-induced apoptosis. 28
DNA ligase I deficiency activates the ATM-dependent DNA damage checkpoint and affects cell adhesion. 28
Specific inhibition of human DNA ligase adenylation by a distamycin derivative 28
Oncogenetica e proteomica della replicazione 28
Early effects of topoisomerase I inhibition on RNA polymerase II along transcribed genes in human cells. 28
Pre-mRNA processing factors meet the DNA damge response. 27
Correlation between anthracycline structure and human DNA ligase inhibition 27
DNA ligase I gene expression during differentiation and cell proliferation 27
Investigation of Cell Culturing on High-Aspect-Ratio, Three-Dimensional Silicon Microstructures 27
DNA ligase I deficiency activates the ATM-dependent DNA damage checkpoint and affects cell adhesion 26
DNA topoisomerase I: evidence for an additional form in carrot cells 26
Subnuclear distribution of the largest subunit of the human origin recognition complex during the cell cycle. 26
Dynamics of replication compartments during the cell cycle and in response to DNA damaging agents 26
DNA unwinding and inhibition of T4 DNA ligase by anthracyclines 26
Identification of S6K2 as a centrosome-located kinase. 26
Functional characterization of the T4 DNA ligase: a new insight into the mechanism of action 26
DNA Polymerases and DNA Topoisomerases as target for development of anticancer drugs 25
DNA ligase I-deficient cell lines as a model for studying the cellular response to endogenous DNA damages 25
An insight into the proteome of 46BR.1G1 fibroblasts established from a patient affected by DNA ligase I-deficiency syndrome 25
Risposta allo stress termico: un modello per lo studio del controllo spazio-temporale della replicazione dell eterocromatina costitutiva. 25
Detection of the effects of intercalating and non-intercalating drugs on DNA structure 25
Potentiation of dopamine-induced cAMP formation by group I metabotropic glutamate receptors via protein kinase C in cultured striatal neurons 25
Totale 4.524
Categoria #
all - tutte 17.547
article - articoli 10.205
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 933
Totale 28.685


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/20242 0 0 0 0 0 0 0 0 2 0 0 0
2024/20251.726 3 10 119 78 547 37 7 87 30 51 412 345
2025/20262.969 129 185 255 374 405 62 422 137 780 120 61 39
2026/2027455 94 116 245 0 0 0 0 0 0 0 0 0
Totale 5.152